Challenging 2012 Predicted for the Pharmaceutical Industry

Ratings agency Fitch has issued a report predicting that the pharmaceutical sector will “continue to experience significant operating challenges” in 2012 but while issuing a negative outlook, they added that pharmaceuticals will still be one of the highest-rated industries. The new analysis comments that the 15 global pharmaceutical companies covered by the report will suffer

Continue Reading

Only Medics’ Sister Company, Clinical Professionals, Achieves Sunday Times Fast Track 100 Top 50 Ranking

Fast Track, in association with the Sunday Times, has this week revealed Britain’s fastest growing private firms. Only Medics’ sister company, Clinical Professionals, was ranked in the Top 50 within The Sunday Times Virgin Fast Track 100 league table for 2011. The league table ranks Britain’s 100 private companies with the fastest-growing sales over their

Continue Reading

Roche Set Up Swiss Academic Translational Centre

Roche yesterday announced that they are increasing their collaborative efforts with academic researchers to deliver the next generation of targeted therapies for unmet medical needs by creating an external academic translational research hub in their home market. The hub in Zurich, Switzerland will be four-way collaboration between Roche, ETH (the Swiss Federal Institute of Technology)

Continue Reading

Pharmaceutical Industry Receives Boost from UK Government Plans to Improve Medicine Access

Earlier access to new medicines and automatic inclusion of NICE-recommended treatments onto local formularies are some of the many measures included in a package announced yesterday by the UK Prime Minister, David Cameron, as part of the UK’s Life Sciences Strategy and the NHS Chief Executive, Sir David Nicholson’s, Review of Innovation. The strategy provides

Continue Reading

Eli Lilly Conduct Study into the Barriers of Progression in Insulin Treatment

Eli Lilly and Company yesterday announced that they are conducting the first major international, prospective observational study intended to understand the real-world difficulties that people with type 2 diabetes face that result in preventing them from attainment their ultimate treatment goals. Many people with diabetes who take daily insulin resist a progression of insulin therapy

Continue Reading